Obesity-Related Malnutrition Nutrition Market

High-protein low-calorie ONS is estimated at 43.3% of product type demand in 2026, with GLP-1 / pharmacotherapy users at 48.9% by context and RTD at 49.9% by product form. Adoption rises where reduced intake leaves a defined nutrition gap, but funding and tolerability can interrupt repeat use.